Skip to content

Tine Carmeliet

Senior Associate


Carmeliet Tine
Tine Carmeliet

Senior Associate


Tine is a Senior Associate in Allen&Overy's Life Sciences Practice.

She specializes in life sciences patents litigation and advises clients on regulatory issues and commercial transactions in the life science sector. Her litigation experience includes both representing clients before the Belgian and European courts and assisting clients with multi-jurisdictional proceedings. She also advices clients on issues on the entire life cycle of a medicinal product, MDR and IVDR, digital health solutions, real world data and transparency regulations) and is specialised in agro(bio)tech and food and feed regulations (new breeding techniques and Nagoya Protocol).

She also has a sound life sciences policy understanding thanks to her secondment to the European Federation of Pharmaceutical Industries Associations legal team, where she focused on regulatory and IP policy.

Recent highlights of her practice include multi-jurisdictional advice on European plant and seed legislation and genetically modified organisms, clinical trials, complex cross-border data protection matters and medical devices. Tine also conducts intellectual property litigation before the Belgian courts and advises clients on non-contentious matters in that field of expertise.

Related articles

Person picking medicine packet off shelf

Blog Post: 28 November 2022

Webinar - EU developments in pricing and reimbursement

Keeping up with current developments regarding pricing and reimbursement of pharmaceuticals is crucial for planning efficient and successful market access strategies. The regulatory framework…

Read more

Blog Post: 18 October 2022

Paediatric medicines in the EU, the UK and the U.S.: regulatory framework in a nutshell

Read more

Blog Post: 24 February 2022

Potential EU regulation for the compulsory licensing of patents to be studied by the European Commission

Read more

Blog Post: 25 January 2022

Belgian medicines agency updates procedure to remove patented indications from SmPC and package leaflet

Read more



Intellectual Property


Life Sciences



Tervurenlaan 268A avenue de Tervueren

View office →



LLM, University of Leuven, 2013

Master of Arts, The Johns Hopkins University Paul H. Nitze School of Advanced International Studies, 2015

Awards & accolades

Trailblazer in most influential women in IP

World Intellectual Property Review (2020)

Jura Falconis First Prize

Master thesis

Entrepreneurship Award

Union of Self- Employed Entrepreneurs with & AFC

Published work

  • CARMELIET, T., VAN DYCK, P., ""It’s time to amend the Enforcement Directive to ensure all EU Member States provide for declarations of non-infringement of EUTMs and Community designs."" (ed. STONE, D. & POTTS, B.), Journal of Intellectual Property Law & Practice, Volume 14, Issue 10, October 2019, Pages 754–760
  • CARMELIET, “The Gx contribution to multilateral trade governance: balancing efficiency and inclusiveness”, Hart Publishing, 2018.
  • G. GLAS and T. CARMELIET, “The European Court of Justice to rule on milestone in European GMO legislation: the legal classification of mutagenesis in plant breeding”, the Bioscience Law Review 2017, Volume 16, Issue 2, Page 91.
  • E. VAN KEYMEULEN and T. CARMELIET, ““Sunshine” in Belgium: new statutory transparency requirements for life sciences companies”, European Pharmaceutical Law Review 2017, Pages 26-31.
  • T. CARMELIET AND G. KOSMIDOU, “Enforcing Europe’s Foundational Values. Central and Eastern Europe: A Case in Point”, European Judicial Systems as a Challenge for Democracy, Intersentia, Antwerp, 2015.
  • T. CARMELIET, “A Critical Analysis of the Procedural Fairness of the Leniency Instrument. Finding the Right Balance Between Efficiency and Justice in EU Competition Law”, Jura Falconis 2013-2014, Page 2.